AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Growth hormone (GH) plays a crucial role in determining height during adolescence and is responsible for the growth of tissues. It declines significantly in adulthood and continues to drop as one gets older. While GH is not essential in adulthood, some proponents claim it can help optimize fat loss, vitality, and overall function. However, the evidence is lacking, and the benefits and risks can vary depending on individual factors such as baseline insulin-like growth factor 1 (IGF-1) levels and overall health. GH is used clinically for GH deficiency in adolescents but is not widely prescribed for other purposes and does not have FDA approval for anti-aging or longevity purposes.
GH has various clinical applications, such as aiding in the recovery of burn victims and potentially promoting the healing of orthopedic injuries. While the evidence is limited, anecdotal reports suggest that using GH and anabolic steroids during rehabilitation may lead to positive outcomes. GH has also been explored for its potential effects on osteopenia and osteoporosis, though the evidence in this area is inconclusive. Overall, the clinical use of GH in specific medical contexts requires further investigation and tailored approaches based on individual factors.
Peptides such as GHRP (Growth Hormone-Releasing Peptide) and GHRH (Growth Hormone-Releasing Hormone) are often used in combination to enhance GH production. For example, IPamorelin and MK677 are commonly prescribed. GHRP compounds primarily stimulate the ghrelin receptor, while GHRH compounds mimic the effects of GHRH. These peptides have various effects on hunger, sleep, and IGF-1 production. The FDA has approved some peptides for specific medical conditions, but many others are used off-label or prescribed in anti-aging clinics without official approval. Clinicians often combine GHRP and GHRH to maximize the body's endogenous GH production.
The hypothalamus releases gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to produce luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH acts on Leydig cells in the testes to stimulate testosterone production, while FSH acts on Sertoli cells to support sperm production. This axis is tightly regulated through negative feedback loops, with testosterone and estrogen levels influencing the production and release of GnRH and LH.
Testosterone can be converted into dihydrotestosterone (DHT) or estrogen (estradiol). DHT is the most potent androgen, responsible for masculinizing effects and sexual differentiation during development. Testosterone and DHT bind to the androgen receptor, translocating to the nucleus and acting as transcription factors to regulate gene expression, including muscle protein synthesis. Estrogen, on the other hand, exerts feminizing effects and regulates a balance with androgens. The conversion and balance between these hormones depend on factors such as aromatase activity, adipose tissue, and genetic factors.
Androgenic effects refer to the masculinizing and masculinizing properties of hormones, while anabolic effects are related to muscle growth and protein synthesis. DHT is highly androgenic and promotes masculine characteristics, while testosterone, along with its metabolism into DHT, has both androgenic and anabolic effects. The balance between androgenic and anabolic properties varies between individuals and can be influenced by factors such as lifestyle, genetics, and hormone levels.
The use of testosterone and other androgens comes with considerations and potential side effects. These may include cardiovascular effects, impact on fertility and hormone regulation, as well as concerns related to the misuse or abuse of these substances. It is important to approach the use of androgens with caution and under the guidance of a qualified healthcare professional.
Bodybuilders in the top 50 are typically on anabolic steroids for 90-100% of the year, with testosterone as the base. These bodybuilders are often on high doses of various compounds, including testosterone, to promote muscle growth. They may also use selective androgen receptor modulators (SARMs) for their anabolic effects. The dosages and compounds used vary depending on the individual's goals and preferences. A combination of testosterone and other anabolic agents, such as deca or primobolan, is common during the off-season, while preparing for a contest may involve higher doses and different compounds. The management of estrogen levels and the prevention of gynecomastia are also important considerations for bodybuilders.
Recovery of natural testosterone production after prolonged use of anabolic steroids is possible but can be challenging. Some individuals have successfully restored endogenous production after being shut down for years, but the process requires a thoughtful approach to post-cycle therapy and bridging into recovery. Strategies may involve the use of human chorionic gonadotropin (HCG) to preserve testicular function and stimulate hormone production. The timing and duration of drug clearance, as well as individual responses to gonadotropins, play a role in achieving successful recovery. However, the long-term consequences and potential limitations of recovery following prolonged steroid use are not well understood.
Bodybuilders often navigate complex drug regimens and risks in pursuit of their goals. The selection of drugs is based on individual responses, desired outcomes, and the management of side effects. Estrogen management is crucial, and some bodybuilders use aggressive aromatase inhibitors and SERMs (selective estrogen receptor modulators) to prevent gynecomastia. However, the use of high doses of androgens and the suppression of estrogen can have negative health consequences, including neurotoxicity. Gynecomastia surgery may be required for individuals who develop breast tissue growth. Overall, bodybuilders face the challenge of balancing muscle growth and contest preparation with minimizing side effects and maintaining health.
The podcast episode discusses the importance of closely monitoring hormone levels in individuals using drugs such as testosterone or nandrolone. It highlights that standard immunoassay testing may not accurately reflect the actual dosage of these compounds, leading to misinterpretations of hormone levels. Additionally, certain supplements may interfere with hormone testing. The episode emphasizes the need for more accurate and sensitive testing methods, such as liquid chromatography with tandem mass spectrometry, to ensure proper monitoring of hormone levels and avoid potential health risks.
The podcast delves into the roles of HCG and Clomid in fertility and hormone regulation. It explains that HCG, a compound found in pregnant women's urine, can stimulate the luteinizing hormone receptor and help maintain testicular function, making it crucial for individuals on testosterone replacement therapy who wish to preserve fertility. On the other hand, Clomid, a selective estrogen receptor modulator, can stimulate the production of testosterone by tricking the brain into thinking it's estrogen deprived. While HCG is not FDA-approved for certain uses, it is commonly prescribed and used. The episode also mentions the potential benefits and risks of using nClomid, a specific stereoisomer of Clomid that may have more selective and antagonistic activity.
View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter’s Weekly Newsletter
We discuss:
Connect With Peter on Twitter, Instagram, Facebook and YouTube
Listen to all your favourite podcasts with AI-powered features
Listen to the best highlights from the podcasts you love and dive into the full episode
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
Listen to all your favourite podcasts with AI-powered features
Listen to the best highlights from the podcasts you love and dive into the full episode